FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2040812 · Received March 24, 2011

Report

Report Number
9612164-2011-00106
Event Type
Death
Date Received
March 24, 2011
Date of Event
July 3, 2010
Report Date
February 28, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION RESULTS: (DEATH).

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE THE PATIENT HAD ONE ENDEAVOR SPRINT RX DRUG-ELUTING STENT IMPLANTED TO THE MID LAD AND ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 1ST OBTUSE MARGINAL. PATIENT WAS ASYMPTOMATIC/FREE OF SYMPTOMS AT 30 DAY, 6 MONTH FOLLOW-UP. PATIENT WAS REPORTED TO HAVE SUFFERED A SPONTANEOUS INTRAOCULAR BLEED APPROXIMATELY 11 MONTHS POST INDEX PROCEDURE. INVESTIGATOR ASSESSED THERE WAS NO RELATIONSHIP BETWEEN THE EVENT AND THE STUDY DEVICE. PATIENT WAS ASYMPTOMATIC/FREE OF SYMPTOMS AT 1 YEAR AND 1.5 YEAR FOLLOW UP. PATIENT DEATH IS REPORTED TO HAVE OCCURRED APPROXIMATELY 27 MONTHS POST INDEX PROCEDURE. DEATH WAS ASSESSED AS A NON-SUDDEN DEATH. NON OTHER INFORMATION IS CURRENTLY AVAILABLE. (REF MFR # 9612164-2011-00107)

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA 0000534179

Patients

Seq Age Sex Outcome Treatment
1 78 YR Death CLOPIDOGREL| ASPIRIN